Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma.
about
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@en
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@nl
type
label
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@en
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@nl
prefLabel
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@en
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Safety and efficacy of vismode ...... advanced basal cell carcinoma.
@en
P2093
Aleksandar Sekulic
Anne Lynn S Chang
Bann-Mo Day
Edward F McKenna
James A Solomon
Karl D Lewis
Michael R Migden
P2860
P304
76118-76124
P356
10.18632/ONCOTARGET.12660
P407
P577
2016-10-14T00:00:00Z